XML 22 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 235,030 $ 1,069,582
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 44,324 38,361
Deferred tax expense (benefit) 111,191 (698,177)
Realized investment gains, net (8,984) (27,133)
Excess tax benefits related to share-based compensation (100) (2,113)
Loss on debt extinguishment 31,071 0
Payment of original issue discount-convertible junior subordinated debentures (41,540) 0
Payment of original issue discount-convertible senior notes (11,250) 0
Change in certain assets and liabilities:    
Accrued investment income (2,086) (6,343)
Prepaid insurance premium 95 47,436
Reinsurance recoverable on loss reserves (2,376) 19,093
Reinsurance recoverable on paid losses (1,313) 2,149
Premium receivable 1,048 5,863
Deferred insurance policy acquisition costs (2,167) (2,757)
Profit commission receivable (2,005) 91,500
Loss reserves (357,919) (416,864)
Premium deficiency reserve 0 (23,751)
Unearned premiums 41,353 61,705
Return premium accrual (12,800) (6,400)
Income taxes payable - current 822 752
Other 9,235 (17,872)
Net cash provided by operating activities 31,629 135,031
Purchases of investments:    
Fixed maturities (1,105,995) (1,970,402)
Equity securities (4,315) (2,593)
Proceeds from sales of fixed maturities 718,894 1,527,680
Proceeds from maturity of fixed maturities 432,557 432,328
Proceeds from sale of equity securities 6,425 0
Net increase in payable for securities 3,376 48,120
Net decrease in restricted cash 0 17,212
Additions to property and equipment (4,969) (2,835)
Net cash provided by investing activities 45,973 49,510
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 573,094 0
Purchase of convertible senior notes (363,778) 0
Purchase of convertible junior subordinated debentures-liability component (91,110) 0
Purchase of convertible junior subordinated debentures-equity component (9,750) 0
Purchase of common stock (91,597) 0
Payment of debt issuance costs (938) 0
Excess tax benefits related to share-based compensation 100 2,113
Net cash provided by financing activities 16,021 2,113
Net increase in cash and cash equivalents 93,623 186,654
Cash and cash equivalents at beginning of period 181,120 197,882
Cash and cash equivalents at end of period $ 274,743 $ 384,536